Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) - Total Liabilities

Latest as of March 2026: TL648.60 Million TRY ≈ $14.53 Million USD

Based on the latest financial reports, Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has total liabilities worth TL648.60 Million TRY (≈ $14.53 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) asset resilience to evaluate the company's liquid asset resilience ratio.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS - Total Liabilities Trend (2018–2025)

This chart illustrates how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Meditera Tibbi Malzeme Sanayi ve Ticaret.

Meditera Tibbi Malzeme Sanayi ve Ticaret AS Competitors by Total Liabilities

The table below lists competitors of Meditera Tibbi Malzeme Sanayi ve Ticaret AS ranked by their total liabilities.

Company Country Total Liabilities
Panstar Enterprise Co.Ltd
KQ:054300
Korea ₩58.94 Billion
STG International Ltd
TA:STG
Israel ILA46.77 Million
Surapon Foods Public Company Limited
BK:SSF
Thailand ฿1.38 Billion
Lohakit Metal Public Company Limited
BK:LHK
Thailand ฿425.43 Million
Lake Victoria Gold Ltd.
V:LVG
Canada CA$4.53 Million
RIT Capital Partners
LSE:RCP
UK GBX438.60 Million
Hyundai HT CoLtd
KQ:039010
Korea ₩31.05 Billion
MODULIGHT OY EO 1
F:78W
Germany €4.01 Million

Liability Composition Analysis (2018–2025)

This chart breaks down Meditera Tibbi Malzeme Sanayi ve Ticaret AS's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See MEDTR net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.58 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.21 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.17 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Meditera Tibbi Malzeme Sanayi ve Ticaret AS's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)

The table below shows the annual total liabilities of Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2018 to 2025.

Year Total Liabilities Change
2025-12-31 TL661.10 Million
≈ $14.81 Million
-12.18%
2024-12-31 TL752.75 Million
≈ $16.86 Million
+26.19%
2023-12-31 TL596.54 Million
≈ $13.36 Million
+180.84%
2022-12-31 TL212.41 Million
≈ $4.76 Million
+41.76%
2021-12-31 TL149.84 Million
≈ $3.36 Million
+20.32%
2020-12-31 TL124.53 Million
≈ $2.79 Million
+32.87%
2019-12-31 TL93.72 Million
≈ $2.10 Million
-1.71%
2018-12-31 TL95.36 Million
≈ $2.14 Million
--

About Meditera Tibbi Malzeme Sanayi ve Ticaret AS

IS:MEDTR Turkey Medical Devices
Market Cap
$42.49 Million
TL1.90 Billion TRY
Market Cap Rank
#22595 Global
#348 in Turkey
Share Price
TL20.00
Change (1 day)
-4.58%
52-Week Range
TL20.00 - TL32.70
All Time High
TL52.90
About

Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi manufactures and sells medical devices in Turkey. The company offers two-way and single-line Infusion Systems; Chemotherapy Preparation and Administration Systems, such as medoconco automated drug preparation, diana semi-automatic drug dispensing, and ICU medical chemotherapy drug delivery systems; and respiratory systems products, includin… Read more